FDA report details flaws at Emergent facility making Johnson & Johnson Covid-19 vaccine

The FDA’s inspection of Emergent’s Bayview facility in Baltimore ended Tuesday and a newly released document details issues that could affect quality during manufacturing — including incomplete investigations into cross-contamination, written procedures that weren’t followed, poorly maintained facilities and a lack of employee training. New production was halted at the FDA’s request, Dr. Janet Woodcock, […]